Stage Information for Pancreatic Cancer
The staging system for pancreatic exocrine cancer continues to evolve. The importance of staging beyond that of resectable and unresectable is uncertain since state-of-the-art treatment has demonstrated little impact on survival. To communicate a uniform definition of disease, however, knowledge of the extent of the disease is necessary. Cancers of the pancreas are commonly identified by the site of involvement within the pancreas. Surgical approaches differ for masses in the head, body, tail, or uncinate process of the pancreas.
Definitions of TNM
The American Joint Committee on Cancer has designated staging by TNM classification to define pancreatic cancer.[1]
Table 1. Primary Tumor (T)a
| TX | Primary tumor cannot be assessed. |
| T0 | No evidence of primary tumor. |
| Tis | Carcinoma in situ.b |
| T1 | Tumor limited to the pancreas, ?2 cm in greatest dimension. |
| T2 | Tumor limited to the pancreas, >2 cm in greatest dimension. |
| T3 | Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. |
| T4 | Tumor involves the celiac axis or the superior mesenteric artery (unresectable primary tumor). |
Table 2. Regional Lymph Nodes (N)a
| NX | Regional lymph nodes cannot be assessed. |
| N0 | No regional lymph node metastasis. |
| N1 | Regional lymph node metastasis. |
Table 3. Distant Metastasis (M)a
| M0 | No distant metastasis. |
| M1 | Distant metastasis. |
Table 4. Anatomic Stage/Prognostic Groupsa
| Stage | T | N | M |
| 0 | Tis | N0 | M0 |
| IA | T1 | N0 | M0 |
| IB | T2 | N0 | M0 |
| IIA | T3 | N0 | M0 |
| IIB | T1 | N1 | M0 |
| T2 | N1 | M0 | |
| T3 | N1 | M0 | |
| III | T4 | Any N | M0 |
| IV | Any T | Any N | M1 |
References:
WebMD Public Information from the National Cancer Institute
